Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients

Allergology International

Volumn 53, Issue 3, 2004, Pages 245-254

  Okubo, Kimihiro ^a   Gotoh, Minoru ^d   Shimada, Kenichi ^a   Ritsu, Masayo ^a   Kobayashi, Makoto ^b   Okuda, Minoru ^a,c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Crecon Research and Consulting Inc   (Japan)

^c Japan Clinical Allergy Research Institute   (Japan)

^d NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

Author keywords

Allergic rhinitis; Cedar pollinosis; Daily life; Fexofenadine; Quality of life

Indexed keywords

FEXOFENADINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; EMOTION; FEMALE; HEADACHE; HUMAN; JAPANESE CEDAR; MAJOR CLINICAL STUDY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; SOCIAL INTERACTION; TREATMENT OUTCOME;

EID: 4744375274     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1592.2004.00341.x     Document Type: Article

References (12)

1. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann. Allergy Asthma Immunol. 2003; 91: 288-96.
2. Okuda M. Allergic Rhinitis QOL Questionnaire: The development and clinical usage. Jpn. J. Allergol. 2003; 52 (Suppl. 1): 1-20 (in Japanese).
3. Fukuroku K, Hagino S. Quality of life in patients with perennial allergic rhinitis: Using the Japanese version of the SF-36 health status questionnaire. Jpn. J. Allergol. 2001; 50: 385-93.
4. Juniper EF. Measuring health-related quality of life in rhinitis. J. Allergy Clin. Immunol. 1997; 99: 742-9.
5. Meltzer E, Casale T, Nathan R, Tompson T. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 1999; 83: 311-17.
6. Okuda M, Okubo K, Gotoh M et al. Japanese Allergic Rhinitis Standard QOL Questionnaire (2002). Jpn. J. Allergol. 2003; 52 (Suppl. 1): 21-56 (in Japanese).
7. Juniper E, Guyatt G, Griffith L, Ferrie P. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J. Allergy Clin. Immunol. 1996; 98: 843-5.
8. Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am. J. Managed Care 1999; 5 (Suppl.): S235-47.
9. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J. Am. Acad. Dermatol. 2000; 43: 24-30.
10. Meltzer EO, Thomas BC, Robert AN, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 1999; 83: 311-17.
11. Van Cauwenberge P, Juniper E and the STAR Study Investigating Group. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin. Exp. Allergy 2000; 30: 891-9.
12. Crawford B, Okuda M. Psychometric validation of Japanese translation of the RQLQ and WPAI-AS. J. Allergy Clin. Immunol. 2003; 111: 428 (Abstract).